Literature DB >> 31886148

Maximum Decompressive Hemicraniectomy for Patients with Malignant Hemispheric Infarction.

Youngseok Kwak1, Byoung-Joon Kim2, Jaechan Park2.   

Abstract

OBJECTIVE: The authors applied maximum external decompression for malignant hemispheric infarction and investigated the functional outcome according to the patient age.
METHODS: Twenty-five patients with malignant hemispheric infarction were treated using a hemicraniectomy with maximum external decompression, comprising a larger (>14cm) hemicraniectomy, resection of the temporalis muscle and its fascia, spaciously expansive duraplasty, and approximation of the skin flap. The medical and diagnostic imaging records for the patients were reviewed, and 1-year functional outcome data obtained for the younger group (aged ≤ 60 years) and elderly group (aged > 60 years).
RESULTS: The patients (n=25) who underwent maximum surgical decompression revealed a minimal mortality rate (n=2, 8.0%). The patients (n=14) in the younger group all survived with mRS scores of 2 (n=1, 7.1%), 3 (n=7, 50.0%), 4 (n=3, 21.4%), or 5 (n=3, 21.4%). A majority of the younger patients (57.1% with mRS ≤3) lived with functional independence. When the 1-year mRS scores were dichotomized between favorable (mRS ≤3) and unfavorable (mRS ≥4) outcomes, the younger group had significantly more patients with a favorable outcome than the elderly group (57.1% versus 9.1%, p=0.033). In contrast, in the elderly group, most patients showed unfavorable outcomes with the mRS scores of 4 (n=5, 45.5%), 5 (n=3, 27.3%), or 6 (n=2, 18.2%), whereas only one patient showed favorable outcome (mRS 3). A majority of the elderly patients (45.5% with mRS 4) survived with moderately severe disability.
CONCLUSION: For malignant hemispheric infarction, a hemicraniectomy with maximum external decompression was found to considerably increase survival with a favorable outcome in functional independence (mRS ≤3) for younger patients aged ≤60 years. It can be optimal surgical treatment for younger patients.
© 2019 Journal of Cerebrovascular and Endovascular Neurosurgery.

Entities:  

Keywords:  Cerebral infarction; Decompressive hemicraniectomy; Surgical decompression; Temporalis muscle; Treatment outcome

Year:  2019        PMID: 31886148      PMCID: PMC6911931          DOI: 10.7461/jcen.2019.21.3.138

Source DB:  PubMed          Journal:  J Cerebrovasc Endovasc Neurosurg        ISSN: 2234-8565


INTRODUCTION

Despite any medical treatment, malignant hemispheric infarction induced by acute occlusion of either the internal carotid artery (ICA) or proximal middle cerebral artery (MCA) has a high mortality related to massive brain swelling and cerebral herniation.13) However, surgical decompression with a hemicraniectomy is an efficient way to reduce the risk of fatal cerebral herniation by allowing the infarcted swollen brain to expand outside the cranium.2)3)4)6)8)12)14) The positive effects of decompressive surgery for malignant hemispheric infarction were approved based on the recent multi-center randomized clinical trials.8)14) However, the surgical techniques applied in these recent clinical trials, comprising a hemicraniectomy with a diameter >12cm, expansive duraplasty, and approximation of the temporalis muscle and skin flap, would seem to be suboptimal for maximizing external herniation of infarcted brain tissue.5)7)8)15) Accordingly, the authors applied maximum external decompression for malignant hemispheric infarction, comprising a larger (>14cm) hemicraniectomy, spaciously expansive duraplasty, resection of the temporalis muscle and its fascia, and approximation of the skin flap. The functional outcome was then investigated and compared with the historical control using a conventional surgical technique.

MATERIALS AND METHODS

Patient population and data collection

From January 2011 to December 2014, 25 patients with malignant hemispheric infarction were treated using a decompressive hemicraniectomy with resection of the temporalis muscle at the authors' institution. The inclusion criteria for this study included 1) age ≥20 years, 2) acute ischemic stroke in the MCA territory, with or without additional infarction in the territory of the ACA or PCA, 3) occlusion of either the ICA or proximal MCA, 4) maximum external decompression with resection of the temporalis muscle and fascia, 5) timely operation without delay, and 5) evaluation of the 1-year functional outcome using mRS. Meanwhile, the exclusion criteria included 1) acute infarction in the whole cerebral hemisphere and 2) bilateral fixed dilated pupils. The medical and diagnostic imaging records for the patients were reviewed, including the demographics, clinical characteristics, GCS score at admission, NIHSS score at admission, preoperative infarct volume as shown on CT scans, and time interval between ischemic stroke and surgical decompression. In addition, the 1-year functional outcome data was obtained based on documentation from follow-up visits to the outpatient clinic or a simplified mRS questionnaire conducted over the phone by an independent observer (B.K.).1) A favorable or unfavorable functional outcome was determined based on a dichotomization of the mRS score, 0 (no symptoms at all) to 3 (moderate disability) and 4 (moderately severe) to 6 (death), respectively.

Maximum external decompression

Timely surgical decompression was performed. The operation was done before or immediately after any neurological deterioration related to brain swelling, including an altered consciousness level, pupil asymmetry, and aggravated hemiparesis.9)13) The surgical technique used to achieve maximum external decompression was previously reported as a technical note by the current authors.10) The scalp is elevated using a large question-mark incision with a posterior limit of 5 cm from the external auditory canal. The temporalis muscle and its fascia are then resected at the level of the zygomatic arch. This reduces the temporal lobe compression from the swollen temporal muscle and augments the expansibility of the extradural soft tissue for free external herniation of the swollen brain (Fig. 1).
Fig. 1

Intraoperative photograph showing hemicraniectomy with maximum external decompression. The temporalis muscle (arrows) and its fascia are cut at the level of the zygomatic arch.

The hemicraniectomy involves the removal of a large fronto-temporo-parietal bone flap with a posterior limit of 5 cm from the external auditory canal and superior limit of 2 cm from the midline. The anteroposterior diameter of the bone flap should be larger than 14 cm. Following a stellate-shaped dural incision, expansive duraplasty is performed spaciously using an artificial dura substitute. The infarcted brain tissue is not removed except in extremely severe cases, such as severe hemorrhagic transformation or whole hemispheric infarction. Meticulous hemostasis and placement of closed suction drains are performed to prevent a postoperative subgaleal hematoma, and the overlying skin is approximated.

Statistical analysis

The statistical analyses were performed with the aid of commercially available statistics software (SPSS version 19.0; IBM Corp., New York, United States). The statistical tests used to determine the significance of the differences in the variables are listed in the data tables. The results were considered significant for probability values less than 0.05.

RESULTS

Patient characteristics

A summary of the patient characteristics, including the clinical and radiological characteristics, and 1-year functional outcomes, is shown in Table 1. The patients were grouped into younger (age ≤60 years) and elderly (age >60 years) patients. It enabled us to compare the results with the previous reports in literature.8)14) The mean age of the younger group was 47.6±8.9 years (range, 31–59 years), while a mean age of the elderly group was 67.0±3.9 years (range, 61–73 years).
Table 1

Characteristics and 1-year functional outcomes for infarcted patients after hemicraniectomy with maximum external decompression

Patient CharacteristicsNo. (%) of Patientsp Value*
Aged ≤ 60 years (n=14)Aged > 60 years (n=11)
Gender0.116
 Male10 (71.4)4 (36.4)
 Female4 (28.6)7 (63.6)
Infarcted hemisphere0.042
 Dominant side7 (50.0)4 (36.4)
 Non-dominant side7 (50.0)7 (63.6)
Occluded vessel0.350
 ICA2 (14.3)4 (36.4)
 Proximal MCA12 (85.7)7 (63.6)
Time interval between stroke onset and craniectomy0.622
 Mean±SD (hrs)38.7±19.834.8±18.8
 Range (hrs)19-7918-73
GCS at admission0.688
 Mean±SD12.0±2.711.5±2.8
 Range8-158-15
NIHSS at admission0.811
 Mean±SD18.9±3.019.3±5.5
 Range15-2516-33
Preoperative infarct volume on CT scans0.914
 Mean±SD (mL)276.7±57.6273.5±68.7
 Range (mL)170-362185-380
1-year mRS0.033
 0-38 (57.1)1 (9.1)
 4-66 (42.9)10 (90.9)

CT : computed tomography, DW : diffusion-weighted, GCS : Glasgow Coma Scale, mRS : modified Rankin Scale, NIHSS : National Institutes of Health Stroke Scale, SD : standard deviation.

*Boldface p values indicate significance.

†t-test.

‡Chi-square test.

§Fisher's exact test.

The younger and elderly groups were well matched without statistical difference as regards patient gender, the occluded vessel, time interval between stroke onset and the craniectomy, GCS at admission, NIHSS at admission, and preoperative infarct volume on CT scans. The younger patient population consisted of 10 men (71.4%) and 4 women (28.6%), while the elderly patient population consisted of 4 men (36.4%) and 7 women (63.6%). At admission, the GCS scores ranged from 8 to 15 (mean±SD: 12.0±2.7) for the younger group and also from 8 to 15 (mean±SD: 11.5±2.8) for the elderly group, while the NIHSS scores ranged from 15 to 25 (mean±SD: 18.9±3.0) for the younger group and from 15 to 33 (mean±SD: 19.3±5.5) for the elderly group. Based on the preoperative CT scans, the assessed infarct volume ranged from 170 mL to 362 mL (mean±SD : 276.7±57.6 mL) for the younger group and from 185 mL to 380 mL (mean±SD : 273.5±68.7 mL) for the elderly group. Decompressive surgery was performed before or immediately after neurological deterioration due to brain swelling. For the younger group, the time interval between stroke onset and the craniectomy ranged from 19 hrs to 79 hrs (mean±SD : 38.7±19.8 hrs), with the operation occurring within ≤48 hours in the case of 10 patients (71.4%) and >48 hours in the case of 4 patients (28.6%). Meanwhile, for the elderly group, the time interval between stroke onset and the craniectomy ranged from 18 hrs to 73 hrs (mean±SD : 34.8±18.8 hrs), with the operation occurring within ≤48 hours in the case of 8 patients (72.7%) and >48 hours in the case of 3 patients (27.3%).

1-year functional outcomes

The patients (n=25) who underwent maximum surgical decompression revealed a minimal mortality rate (n=2, 8.0%). The reduced mortality resulted in survival with or without functional independence. The patients (n=14) in the younger group all survived with mRS scores of 2 (n=1, 7.1%), 3 (n=7, 50.0%), 4 (n=3, 21.4%), or 5 (n=3, 21.4%). A majority of the younger patients (57.1% with mRS ≤3) lived with functional independence. When the 1-year mRS scores were dichotomized between favorable (mRS ≤3) and unfavorable (mRS ≥4) outcomes, the younger group had significantly more patients with a favorable outcome than the elderly group (57.1% versus 9.1%, p=0.033). In contrast, in the elderly group, most patients showed unfavorable outcomes with the mRS scores of 4 (n=5, 45.5%), 5 (n=3, 27.3%), or 6 (n=2, 18.2%), whereas only one patient showed favorable outcome (mRS 3). A majority of the elderly patients (45.5% with mRS 4) survived with moderately severe disability.

DISCUSSION

The surgical outcome of a hemicraniectomy for malignant infarction was improved when using techniques to obtain maximum external decompression in comparison with the clinical trials using a conventional surgical technique. In addition, this positive effect on the functional outcome was particularly significant for younger patents aged ≤60 years (Table 2). A pooled analysis of three European randomized controlled trials by Vahedi et al.14) for infarcted patients aged ≤60 years revealed that a hemicraniectomy reduced mortality (71% versus 22%) and increased the number of patients with a favorable outcome (21% versus 43%) when compared with conservative treatment. In the current study, maximum external decompression for patients aged ≤60 years showed 0% mortality and a further increased number of patients with a favorable outcome (57%) when compared with the pooled analysis.
Table 2

Comparison between the present study and representative recent clinical trials*

mRSPooled analysis14) (Age ≤60 y)Current DataDESTINY II Trial8) (Age >60 y)
Conservative Treatment (n = 42)Surgery (n = 51)Surgery Age ≤60 y (n = 14)Surgery Age >60 y (n = 11)Surgery (n = 47)Conservative Treatment (n = 62)
0-21 (2)7 (14)1 (7)0 (0)0 (0)0 (0)
38 (19)15 (29)7 (50)1 (9)3 (6)3 (5)
41 (2)16 (31)3 (21)5 (46)15 (32)7 (11)
52 (5)2 (4)3 (21)3 (27)9 (19)5 (8)
630 (71)11 (22)0 (0)2 (18)20 (43)47 (76)

mRS = modified Rankin Scale.

*Values in parentheses are percentage of patients.

For elderly patients aged >60 years, a randomized controlled trial (DESTINY II) by Jüttler et al. revealed that a hemicraniectomy reduced mortality when compared with conservative treatment (76% versus 43%), yet did not increase the number of patients with a favorable outcome when compared with conservative treatment.8) The surgery increased the number of patients with moderately severe disability (mRS 4; 11% versus 32%). In the current study, maximum external decompression further decreased the mortality (18%), while further increasing the number of patients with mRS scores of 4 (46%) when compared with the DESTINY II trial. Notwithstanding, there was no increase in the number of patients with a favorable outcome (mRS ≤3). When compared with a conventional decompressive hemicraniectomy, the maximum external decompression used in the present study was achieved based on the following technical points: 1) larger hemicraniectomy >14 cm, 2) resection of the temporalis muscle to avoid its compression of the temporal lobe, 3) resection of the inelastic temporalis fascia to increase the expansibility of the extradural soft tissue, 4) spacious expansive duraplasty to accommodate further aggravation of brain swelling, and 5) meticulous hemostasis to avoid a postoperative subgaleal hematoma that would reduce the decompressive effect of the surgery. The concept of timely surgery used in this study is based on the results of the observational study by Qureshi et al.11) on the timing of neurological deterioration after massive MCA infarction. In their study, one third of the patients suffered neurological deterioration within 24 hours, another third deteriorated 24–48 hours after stroke onset, and the remaining patients showed later deterioration on day 3–6. The brain swelling and herniation after hemispheric infarction are affected by delayed spontaneous recanalization of the occluded vessel, hemorrhagic transformation of the infarcted brain tissue, and the fluid volume state of the patient. Thus, the appropriate timing for surgery is not simply 24 or 48 hours after stroke onset. Surgical decompression should be performed at the time point before any neurological deterioration related to brain swelling or immediately after the deterioration in a reversible state. The cosmetic problems caused by resection of the temporalis muscle were minimized using a MEDPOR implant (MEDPOR FLEXBLOCK TF2; Porex Surgical, Inc.) during cranioplasty.10) There were no wound problems or surgical site infections in all our cases. The current study has several important limitations. First, it was based on a retrospective review of a small case series from a single institution. Second, the surgical results were compared with a historical control. However, the results of our study shed light on the positive effects of the maximum external decompression technique for younger patients. A larger, prospective randomized study is warranted.

CONCLUSIONS

For malignant hemispheric infarction, a hemicraniectomy with maximum external decompression was found to considerably increase survival with a favorable outcome in functional independence (mRS ≤3) for younger patients aged ≤60 years. It can be optimal surgical treatment for younger patients.
  15 in total

1.  Simplified modified rankin scale questionnaire: reproducibility over the telephone and validation with quality of life.

Authors:  Askiel Bruno; Abiodun E Akinwuntan; Chen Lin; Brian Close; Kristin Davis; Vanessa Baute; Tia Aryal; Desiree Brooks; David C Hess; Jeffrey A Switzer; Fenwick T Nichols
Journal:  Stroke       Date:  2011-06-16       Impact factor: 7.914

2.  Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials.

Authors:  Katayoun Vahedi; Jeannette Hofmeijer; Eric Juettler; Eric Vicaut; Bernard George; Ale Algra; G Johan Amelink; Peter Schmiedeck; Stefan Schwab; Peter M Rothwell; Marie-Germaine Bousser; H Bart van der Worp; Werner Hacke
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182

3.  Surgical management of massive cerebral infarction.

Authors:  Jun Suk Huh; Hyung Shik Shin; Jun Jae Shin; Tae Hong Kim; Yong Soon Hwang; Sang Keun Park
Journal:  J Korean Neurosurg Soc       Date:  2007-10-20

4.  Surgical decompression for space-occupying cerebral infarction: outcomes at 3 years in the randomized HAMLET trial.

Authors:  Marjolein Geurts; H Bart van der Worp; L Jaap Kappelle; G Johan Amelink; Ale Algra; Jeannette Hofmeijer
Journal:  Stroke       Date:  2013-07-18       Impact factor: 7.914

5.  Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial.

Authors:  Jeannette Hofmeijer; L Jaap Kappelle; Ale Algra; G Johan Amelink; Jan van Gijn; H Bart van der Worp
Journal:  Lancet Neurol       Date:  2009-03-05       Impact factor: 44.182

6.  Brain edema after stroke. Clinical syndrome and intracranial pressure.

Authors:  A H Ropper; B Shafran
Journal:  Arch Neurol       Date:  1984-01

7.  Timing of neurologic deterioration in massive middle cerebral artery infarction: a multicenter review.

Authors:  Adnan I Qureshi; Jose I Suarez; Abutaher M Yahia; Yousef Mohammad; Guven Uzun; M Fareed K Suri; Osama O Zaidat; Cenk Ayata; Zulfiqar Ali; Robert J Wityk
Journal:  Crit Care Med       Date:  2003-01       Impact factor: 7.598

8.  External decompressive craniectomy including resection of temporal muscle and fascia in malignant hemispheric infarction.

Authors:  Jaechan Park; Ealmaan Kim; Gyoung-Ju Kim; Yun-Kyung Hur; Murali Guthikonda
Journal:  J Neurosurg       Date:  2009-01       Impact factor: 5.115

9.  Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial).

Authors:  Katayoun Vahedi; Eric Vicaut; Joaquim Mateo; Annie Kurtz; Mikael Orabi; Jean-Pierre Guichard; Carole Boutron; Gregory Couvreur; François Rouanet; Emmanuel Touzé; Benoît Guillon; Alexandre Carpentier; Alain Yelnik; Bernard George; Didier Payen; Marie-Germaine Bousser
Journal:  Stroke       Date:  2007-08-09       Impact factor: 7.914

10.  Clinical course and surgical management of massive cerebral infarction.

Authors:  Scott C Robertson; Peter Lennarson; David M Hasan; Vincent C Traynelis
Journal:  Neurosurgery       Date:  2004-07       Impact factor: 4.654

View more
  1 in total

1.  Decompressive hemicraniectomy for acute ischemic stroke associated with coronavirus disease 2019 infection: Case report and systematic review.

Authors:  Kevin Ivan Peñaverde Chan; Alaric Emmanuel Mendoza Salonga; Kathleen Joy Ong Khu
Journal:  Surg Neurol Int       Date:  2021-03-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.